| ADR Ontology |
| ADR Term |
Methaemoglobinaemia |
| ADR ID |
BADD_A02767 |
| ADR Hierarchy |
|
| Description |
The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed) [MeSH] |
| MedDRA Code |
10027496 |
| MeSH ID |
D008708
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
|
| Synonym |
| Acquired methaemoglobinaemia | Methaemoglobinaemia | Methaemoglobinaemia NOS | Methemoglobinemia | Acquired methemoglobinemia | Methemoglobinemias |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
